ABIONYX Pharma Market Cap

ABIONYX Pharma has a market cap or net worth of €98.82 million as of June 3, 2026. Its market cap has increased by 122.29% in one year.

Market Cap

98.82M

Enterprise Value

99.10M

Revenue

4.06M

Ranking

n/a

PE Ratio

n/a

Stock Price

€2.78

Market Cap Chart

Since March 30, 2015, ABIONYX Pharma's market cap has decreased from 214.16M to 98.82M, a decrease of -53.86%. That is a compound annual growth rate of -6.68%.

Market Cap History

Date	Market Cap	% Change
Jun 2, 2026	98.82M	-25.99%
Dec 31, 2025	133.53M	223.58%
Dec 31, 2024	41.27M	-0.54%
Dec 29, 2023	41.49M	-14.37%
Dec 30, 2022	48.45M	-28.38%
Dec 31, 2021	67.65M	178.53%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Transgene	228.69M
Cellectis	223.29M
Sensorion	206.40M
Innate Pharma	151.25M
OSE Immunotherapeutics	98.20M
Valerio Therapeutics Société anonyme	96.89M
Adocia	96.67M
MaaT Pharma	53.70M

Market Cap Rankings